These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26740274)

  • 1. Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.
    Papp E; Balogun K; Banko N; Mohammadi H; Loutfy M; Yudin MH; Shah R; MacGillivray J; Murphy KE; Walmsley SL; Silverman M; Serghides L
    J Infect Dis; 2016 May; 213(10):1532-40. PubMed ID: 26740274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction.
    Papp E; Mohammadi H; Loutfy MR; Yudin MH; Murphy KE; Walmsley SL; Shah R; MacGillivray J; Silverman M; Serghides L
    J Infect Dis; 2015 Jan; 211(1):10-8. PubMed ID: 25030058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    McDonald CR; Conroy AL; Gamble JL; Papp E; Hawkes M; Olwoch P; Natureeba P; Kamya M; Silverman M; Cohan D; Koss CA; Dorsey G; Kain KC; Serghides L
    Clin Infect Dis; 2018 Jan; 66(3):428-436. PubMed ID: 29136115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
    Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
    Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.
    Calza L; Manfredi R; Trapani F; Salvadori C; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
    Scand J Infect Dis; 2012 May; 44(5):381-7. PubMed ID: 22263609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
    Kala S; Dunk C; Acosta S; Serghides L
    Hum Reprod; 2020 Aug; 35(8):1781-1796. PubMed ID: 32712670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine.
    Manavi K; McDonald A; Al-Sharqui A
    AIDS; 2007 Mar; 21(5):643-5. PubMed ID: 17314527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation.
    Mohammadi H; Papp E; Cahill L; Rennie M; Banko N; Pinnaduwage L; Lee J; Kibschull M; Dunk C; Sled JG; Serghides L
    Sci Rep; 2018 Apr; 8(1):6552. PubMed ID: 29700323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass.
    Michalik DE; Jackson-Alvarez JT; Flores R; Tolentino-Baldridge C; Batra JS
    J Int Assoc Provid AIDS Care; 2015; 14(2):116-9. PubMed ID: 25361558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.
    Lorenzi P; Spicher VM; Laubereau B; Hirschel B; Kind C; Rudin C; Irion O; Kaiser L
    AIDS; 1998 Dec; 12(18):F241-7. PubMed ID: 9875571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
    Snijdewind IJM; Smit C; Godfried MH; Bakker R; Nellen JFJB; Jaddoe VWV; van Leeuwen E; Reiss P; Steegers EAP; van der Ende ME
    PLoS One; 2018; 13(1):e0191389. PubMed ID: 29351561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy danger.
    Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and possible role of 20alpha-hydroxysteroid dehydrogenase in the placenta of the goat.
    Jayasekara WS; Yonezawa T; Ishida M; Yamanouchi K; Nishihara M
    J Reprod Dev; 2005 Apr; 51(2):265-72. PubMed ID: 15703459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase.
    Piekorz RP; Gingras S; Hoffmeyer A; Ihle JN; Weinstein Y
    Mol Endocrinol; 2005 Feb; 19(2):431-40. PubMed ID: 15471942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decidual prolactin silences the expression of genes detrimental to pregnancy.
    Bao L; Tessier C; Prigent-Tessier A; Li F; Buzzio OL; Callegari EA; Horseman ND; Gibori G
    Endocrinology; 2007 May; 148(5):2326-34. PubMed ID: 17255200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.